The Ninth Circuit held that a seller is liable for misrepresentation of its product's effectiveness if it can only be attributed to the placebo effect using acceptable standards of scientific research. Pantron claimed that it's product reduced hair loss, and cited two European studies to confirm its claim. The FTC claimed that the studies were not held to acceptable scientific research standards, and cited multiple US based studies that held to the contrary using double blind and placebo controlled process that was published in peer reviewed journals.
Full case and summary also available at: http://www.mlmlegal.com/legal-cases/FTC_v_PantronICorp.php
Firefox recommends the PDF Plugin for Mac OS X for viewing PDF documents in your browser.
We can also show you Legal Updates using the Google Viewer; however, you will need to be logged into Google Docs to view them.
Please choose one of the above to proceed!
LOADING PDF: If there are any problems, click here to download the file.
MLM / Direct Sales Updates, MLM Consulting / Network Marketing Updates
Federal, Federal Circuit |
DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.
© Babener & Associates | Attorney Advertising